Time to Test Effects of CBD in Cardiovascular Disease?
Well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease are needed, based on evidence from preclinical studies showing that it has anti-inflammatory effects, a new report suggests. The systematic review of nine preclinical studies found reproducible positive cardiovascular outcomes in in vivo models with CBD. Mechanisms for the findings included reduction in oxidative stress and inflammation.
@navika Cannabidiol and medical cannabis use, alongside its many products, has increased considerably in the last decade, but there are few indications for its use based on good clinical trials